News|Articles|February 25, 2022
NeurologyLive® Friday 5 — February 25, 2022
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 25, 2022.
Advertisement
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: ACTRIMS Forum 2022
The NeurologyLive® team is providing live coverage from the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2022, including on-site video interviews with experts and the latest clinical data readouts and presentations.
2: Mind Moments: Addressing Parkinson Disease Virtually With Prime PD
In Episode 58 of Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Konstantin Karmazin, MD, on the digital wellness studio, Prime PD, and its potential benefits for patients with Parkinson disease and their physicians.
3: NeuroVoices: Andrea Synowiec, DO, on Using a Large-Scale Data Registry to Capture Patient-Reported Outcomes
The assistant director of the Allegheny Headache Center provided context on a recently created headache registry, the need to prioritize treatment outcomes that matter to patients, and her belief that the holistic, patient-centric data the registry captures will help clinicians make more accurate treatment decisions.
4: Peers & Perspectives: Identifying and Evaluating Off-Episodes in Parkinson Disease
In episode 2 of this of NeurologyLive® Peers & Perspectives series, "Parkinson Disease: Managing Off-Episodes," Rajesh Pahwa, MD, and Cynthia Comella, MD, explain the challenges in identifying off-episodes and tactics they use to evaluate them.
5: Epstein-Barr Virus and MS: Exploring Implications From Bench to Bedside
Alberto Ascherio, MD, DrPH, and Lawrence Steinman, MD, join NeurologyLive in a conversation about the clinical and research implications of a causative relationship between Epstein-Barr virus and multiple sclerosis in this NeurologyLive® follow-up discussion.
—————————————————
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Expanding the Alzheimer Drug Development Pipeline
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
FDA Hands Complete Response Letter to SL1009 for Pyruvate Dehydrogenase Complex Deficiency
5